Drug Type Small molecule drug |
Synonyms- |
Target |
Action inhibitors |
Mechanism SMPD3 inhibitors(sphingomyelin phosphodiesterase 3 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC9H10N2O |
InChIKeyKAOBWWMVOBYGHK-UHFFFAOYSA-N |
CAS Registry1103265-45-7 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Vascular Calcification | Preclinical | Netherlands | 19 Jan 2023 |